(Q33544736)

27 July 2017

1 reference

title

Vancomycin-resistant enterococci: the clinical effect of a common nosocomial pathogen. (English)

1 reference

27 July 2017

1 reference

Linden PK

1

1 reference

PubMed ID

10091034

27 July 2017

Miller CB

series ordinal

2

1 reference

27 July 2017

1 February 1999

1 reference

Diagnostic Microbiology and Infectious Disease

27 July 2017

1 reference

27 July 2017

33

1 reference

27 July 2017

2

1 reference

27 July 2017

113-120

1 reference

RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci

27 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Controlling vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Characterization of glycopeptide-resistant enterococci from U.S. hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

An outbreak of vancomycin-resistant Enterococcus faecium in liver transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Vancomycin use in a university medical center: comparison with hospital infection control practices advisory committee guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enterococci with VanA/VanB resistance patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Nosocomial infection with microsphere beds

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Enterococcal bacteremia: to treat or not to treat, a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Successful use of tetracycline as therapy of an immunocompromised patient with septicaemia caused by a vancomycin-resistant enterococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Inappropriate vancomycin prescribing based on criteria from the Centers for Disease Control and Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Nosocomial enterococcal blood stream infections in the SCOPE program: Antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Management of infections due to resistant enterococci: a review of therapeutic options

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Hospital stay and mortality attributed to nosocomial enterococcal bacteremia: a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Hospital-acquired Infection with Vancomycin-resistant Enterococcus faecium Transmitted by Electronic Thermometers

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Enterococcal bacteremia in the surgical intensive care unit. Does vancomycin resistance affect mortality? The Johns Hopkins SICU Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Multiplicity of genetic backgrounds among vancomycin-resistant Enterococcus faecium isolates recovered from an outbreak in a New York City hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Effect of novobiocin-containing antimicrobial regimens on infection and colonization with vancomycin-resistant Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Bloodstream infections with vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Vancomycin-resistant Enterococcus faecium shunt infection in an infant: an antibiotic cure

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

High-level gentamicin resistance in Enterococcus faecalis bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Vancomycin-Resistant Enterococcus faecium in Hospitalized Children

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Quinupristin/dalfopristin (RP 59500) therapy for vancomycin-resistant Enterococcus faecium aortic graft infection: case report

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Risk factors for mortality associated with enterococcal bloodstream infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Nine episodes of CPD-associated peritonitis with vancomycin resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Comparison of patients with enterococcal bacteremia due to strains with and without high-level resistance to gentamicin.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

Colonization pattern of vancomycin-resistant Enterococcus faecium.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900148-5

7 January 2021

10.1016/S0732-8893(98)00148-5

Identifiers

DOI

1 reference

27 July 2017

1 reference

PubMed ID

10091034